Who owns the QLOSI trademark?

The QLOSI trademark is owned by Orasis Pharmaceuticals Ltd..

What class is the QLOSI trademark registered in?

The QLOSI trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for QLOSI?

The USPTO serial number for QLOSI is 97592402.

What is the registration number for QLOSI?

QLOSI is registered under USPTO registration number 8145782.

Sealvo

Home Search: QLOSIQLOSI #97592402

Back

Updated Oct 12, 2026·22 searches this week

View on USPTO TSDR Find similar marks

QLO

USPTO Trademark Record

REGISTERED

QLOSI

SN 97592402·Reg 8145782·Filed Sep 15, 2022

Owner Orasis Pharmaceuticals Ltd.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

QLOSI (Serial No. 97592402), Registration No. 8145782, is a registered US trademark filed on Sep 15, 2022 by Orasis Pharmaceuticals Ltd.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: February 17, 2032

Mark Intelligence

QLOSI (Reg. #8145782) is a registered US trademark that has been protecting its owner, Orasis Pharmaceuticals Ltd., since 2022. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Sep 15, 2022

SERIAL

97592402

REG#

8145782

REGISTERED

Feb 17, 2026

Filing Information

StatusREGISTERED

Filing DateSep 15, 2022

Serial Number97592402

Registration No.8145782

Registration DateFeb 17, 2026

Status DateFeb 17, 2026

Published for OppositionAug 08, 2023

Filing Basis & Declarations

Standard Characters ClaimedUse Application CurrentlyTrademark

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: Apr 01, 2025

First use in commerce: Apr 01, 2025

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

29 events

REGISTERED-PRINCIPAL REGISTER

Feb 17, 2026

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Feb 17, 2026

NOTICE OF REGISTRATION CONFIRMATION EMAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Jan 27, 2026

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Jan 27, 2026

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

STATEMENT OF USE PROCESSING COMPLETE

Jan 26, 2026

STATEMENT OF USE PROCESSING COMPLETE

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Jan 24, 2026

CASE ASSIGNED TO INTENT TO USE PARALEGAL

ASSIGNED TO EXAMINER

Jan 18, 2026

ASSIGNED TO EXAMINER

USE AMENDMENT FILED

Jul 21, 2025

USE AMENDMENT FILED

TEAS STATEMENT OF USE RECEIVED

Jul 21, 2025

TEAS STATEMENT OF USE RECEIVED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Mar 04, 2025

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Jan 29, 2025

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 3 FILED

Jan 29, 2025

SOU EXTENSION 3 FILED

SOU EXTENSION 3 GRANTED

Jan 29, 2025

SOU EXTENSION 3 GRANTED

SOU EXTENSION 2 GRANTED

Oct 01, 2024

SOU EXTENSION 2 GRANTED

SOU TEAS EXTENSION RECEIVED

Oct 01, 2024

SOU TEAS EXTENSION RECEIVED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Oct 01, 2024

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU EXTENSION 2 FILED

Oct 01, 2024

SOU EXTENSION 2 FILED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Mar 13, 2024

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Mar 12, 2024

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 1 FILED

Mar 12, 2024

SOU EXTENSION 1 FILED

SOU EXTENSION 1 GRANTED

Mar 12, 2024

SOU EXTENSION 1 GRANTED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Oct 03, 2023

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Aug 08, 2023

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Aug 08, 2023

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jul 19, 2023

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Jul 02, 2023

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO EXAMINER

Jun 27, 2023

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Sep 29, 2022

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Sep 19, 2022

NEW APPLICATION ENTERED

Other Marks by Orasis Pharmaceuticals Ltd.

Additional USPTO filings from the same owner.

EYE

EYEQ FORMULATION

99020672

Orasis Pharmaceuticals Ltd.

REGISTERED

ISY

90705482

Orasis Pharmaceuticals Ltd.

REGISTERED

CTR

CTRU

90705512

Orasis Pharmaceuticals Ltd.

REGISTERED

VUE

VUENOW

90705660

Orasis Pharmaceuticals Ltd.

REGISTERED

Other Marks by B. Brett Heavner

Additional USPTO filings handled by the same attorney of record.

GRA

GRADUATE MANAGEMENT ADMISSION COUNCIL

86474435

REGISTERED

MYQ

MYQORZO & YOU

99233148

REGISTERED

LUN

LUNSAYIL

79270511

REGISTERED

GSO

G SOLARGRAPH

90878734

REGISTERED

QLOSI

Run a conflict check

Other Marks by Orasis Pharmaceuticals Ltd.

Other Marks by B. Brett Heavner

Get pre-filing clearance

Search 14M+ trademarks

Resources

Company